AXT Inc vs Cardinal Health Inc — how do they compare? AXT Inc trades at $79.01 (market cap $4.83B), while Cardinal Health Inc trades at $240.39 (market cap $55.55B). The key difference: Cardinal Health Inc is far larger — about 11.5× AXT Inc's market cap, and Cardinal Health Inc pays a 0.86% dividend while AXT Inc pays none. Which is the better fit depends on your goals.
| AXTI | CAH | |
|---|---|---|
Market Cap | $4.83B | $55.55B |
Sector | Technology | Health |
52-Week High | $140.83 | $240.26 |
52-Week Low | $2.05 | $146.04 |
Enterprise Value | $4.50B | $60.53B |
Dividend Yield | — | 0.86% |
Signals from Pluang's Aura AI — not financial advice
AXTI trades at $88.58, up 17.84% in 24 hours, reflecting strong momentum after Q2 2026 earnings beat. The stock is technically bullish with support at $82 and resistance at $92. Fundamentally, revenue grew to $126 million in 2026 with a net profit margin of 3.23%, though valuation ratios like P/E of 2,460.33 appear elevated. Recent news highlights surging indium phosphide demand driven by AI data centers.
Outlook is positive with analyst consensus at Buy (72.73%) and a $72.50 price target, but risks include high valuation, cash flow volatility, and dependence on AI-driven demand. The stock offers growth exposure to semiconductor substrates, yet investors should weigh profitability sustainability against rich multiples.
No Aura AI signal available yet.
Trailing returns across standard periods
Latest headlines on both assets
AXT develops and manufactures high-performance compound semiconductor wafer substrates. Its products, like indium phosphide and gallium arsenide, are essential for data centers, 5G, and consumer electronics.
Read more on AXTI →Cardinal Health is a leading pharmaceutical wholesaler, engaged in the sourcing and distribution of branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail-order), hospitals networks, and healthcare providers. Along with AmerisourceBergen and McKesson, the three compose well over 90% of the U.S. pharmaceutical wholesale industry. Cardinal Health also supplies medical-surgical products and equipment to healthcare facilities in North America, Europe, and Asia.
Read more on CAH →